Point72 Hong Kong LTD Alkermes Plc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$26.4 - $32.56 $969,936 - $1.2 Million
36,740 New
36,740 $994,000
Q2 2022

Aug 15, 2022
SELL
$26.4 - $30.54 $152,697 - $176,643
-5,784 Reduced 69.2%
2,574 $77,000
Q1 2022

May 16, 2022
SELL
$23.07 - $27.99 $6,044 - $7,333
-262 Reduced 3.04%
8,358 $220,000
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $185,071 - $276,529
8,620 New
8,620 $201,000
Q3 2021

Nov 15, 2021
SELL
$23.37 - $32.13 $642,978 - $883,992
-27,513 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.78 - $25.15 $516,694 - $691,951
27,513 New
27,513 $675,000
Q1 2021

May 17, 2021
SELL
$18.21 - $23.2 $344,897 - $439,408
-18,940 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $291,486 - $418,574
18,940 New
18,940 $378,000
Q2 2020

Aug 14, 2020
SELL
$13.31 - $19.41 $86,807 - $126,592
-6,522 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$13.06 - $21.24 $85,177 - $138,527
6,522 New
6,522 $94,000
Q3 2019

Nov 14, 2019
SELL
$19.51 - $24.28 $57,652 - $71,747
-2,955 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$21.47 - $37.33 $63,443 - $110,310
2,955 New
2,955 $67,000
Q1 2019

May 15, 2019
SELL
$28.4 - $36.49 $3,152 - $4,050
-111 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$27.94 - $44.61 $3,101 - $4,951
111 New
111 $3,000

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
182M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email